Cover Image

Radiolabeled heterobivalent peptidic ligands: an approach with high future potential for in vivo imaging and therapy of malignant diseases

Show other versions (1)

Two-pronged synergism: We review the recently developed approach of using heterobivalent peptide ligands that interact concomitantly with different receptors on tumor cells. These ligands exhibit highly favorable tumor-targeting properties and pave the way for the development of drugs for specific,...

Full description

Saved in:
Bibliographic Details
Main Authors: Fischer, Gabriel (Author) , Schirrmacher, Ralf (Author) , Wängler, Björn (Author) , Wängler, Carmen (Author)
Format: Article (Journal)
Language:English
Published: 05 April 2013
In: ChemMedChem
Year: 2013, Volume: 8, Issue: 6, Pages: 883-890
ISSN:1860-7187
DOI:10.1002/cmdc.201300081
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/cmdc.201300081
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/cmdc.201300081
Get full text
Author Notes:Gabriel Fischer, Ralf Schirrmacher, Björn Wängler, and Carmen Wängler
Description
Summary:Two-pronged synergism: We review the recently developed approach of using heterobivalent peptide ligands that interact concomitantly with different receptors on tumor cells. These ligands exhibit highly favorable tumor-targeting properties and pave the way for the development of drugs for specific, sensitive, and noninvasive tumor imaging and therapy.
Item Description:Gesehen am 31.03.2022
Physical Description:Online Resource
ISSN:1860-7187
DOI:10.1002/cmdc.201300081

Similar Items